Google Scholar 4 Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al
GLP-1 agonists are not exactly new, although this is a common misconception
Eicosapentaenoic and Docosahexaenoic Acids, Cognition, and Behavior in Children with Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial
The SELECT Trial: Design and Key Findings The SELECT trial enrolled 17,604 patients aged 45 or older with a BMI of 27 or greater and established cardiovascular disease (prior heart attack, stroke, or symptomatic peripheral artery disease), but critically, none had diabetes .[1] This design was intentionalresearchers wanted to understand whether semaglutide's cardiovascular benefits extended beyond its known effects in diabetic populations
They may suggest restarting at a lower dose or adjusting your plan
Maintain consistent calorie intake if you are testing for body composition or use a modest calorie deficit if your goal is fat loss